Skip to main content
Erschienen in: Obesity Surgery 7/2016

11.04.2016 | Letter to the Editor

Conversion of One-Anastomosis Gastric Bypass (OAGB) Is Rarely Needed if Standard Operative Techniques Are Performed

verfasst von: Enrique Luque-de-León, Miguel A. Carbajo

Erschienen in: Obesity Surgery | Ausgabe 7/2016

Einloggen, um Zugang zu erhalten

Excerpt

Although the article by Facchiano et al. [1] is mainly a technical one, we believe it is worthy of some technical and non-technical comments:
1.
Mini-gastric bypass (MGB)/One-anastomosis gastric bypass (OAGB) is currently performed by an increasing number of surgeons around the world [2, 3]. Published experiences have escalated in recent years and are positioning MGB/OAGB as a safe and effective alternative in bariatric/metabolic surgery [24]. Although a controversy has arisen in regard to the name of the procedure [5], this should not divert attention and demerit overall outcomes achieved and reported.
 
2.
The main argument in opposition to MGB/OAGB has been the possibility of bile reflux (BR) and its repercussions. This was critically stated by Johnson et al. [6] in a review from complications managed at different hospitals, whose purpose was to assess (and discredit) the claim that revisional surgery was rarely required in this patient population [7]. This article, however, was full of assumptions, and as previously expressed [8], drawing valid conclusions without a denominator (total number of patients) is impossible. Moreover, no descriptions about operative findings were given, particularly in those cases with “intractable” BR; some may have been similar to the present case [1], which, due to its gastric pouch characteristics, in fact resemble the old (and abandoned) Mason’s loop—see below [9].
 
3.
BR after MGB/OAGB has been reported to be rare, presenting sporadically after specific triggers, usually at night and subsiding after medical treatment [2, 3, 1015]. In addition, BR in these instances has usually been identified clinically and through ancillary studies only in the stomach [10, 12, 16]. Even those highly critical of MGB described “intractable” BR gastritis (and not esophagitis) as the indication to reoperate on their patients [6]. The fact that BR does not reach the esophagus has important implications [17].
 
4.
Fear of cancer due to BR has also been an issue mainly based on older studies from the time of peptic ulcer surgery. Several of these have been contradictory and did not take into account various confounding variables such as Helicobacter pylori [18]. In any case, even the highly criticized Mason’s loop with its proven BR has not been associated with esophageal cancer, and so far, only one case of gastric pouch cancer has been reported 26 years after [19]. Three other cases of cancer after Mason’s loop have been found; however, these were unrelated to BR as they were in the bypassed stomach; cancer in this location has also been identified after other bariatric operations [20]. The MGB/OAGB concept started ∼20 years ago, and after thousands of operated patients, the only case of cancer reported thus far, also originated in the excluded stomach, is an Asian patient 9 years after MGB [21]. This is in contrast to other bariatric operations in which cancer in the gastric reservoir or esophagus has indeed been reported [20].
 
5.
Almost a decade after the cited critical paper by Johnson et al. [6], conversions due to “intractable” reflux have rarely been reported; rates range from 0 % (most MGB/OAGB series) to 0.7 % [2, 3, 7, 1015, 22]. Furthermore, the fact that “intractability” has seldom been described precisely is noteworthy. During the phases of digestive adaptation to MGB/OAGB, some patients experience dyspeptic symptoms which may be due to transient BR, or could be completely unrelated to it; recognizing and classifying them appropriately may avoid unwarranted stress to both patient and surgeon and elude needless reoperations. If after an appropriate diagnostic approach BR is considered to be the problem, medical treatment must be instituted for a reasonable period of time, as some of these symptoms are temporary.
 
6.
On the technical standpoint, it is important to clarify BR was frequent and in fact the reason to abandon Mason’s loop [9]. Its short gastric reservoir was based on the fundus and formed after a high horizontal transection. Since bypassed small bowel averaged <80 cm, undiluted biliopancreatic secretion was placed in close proximity to the esophagus and led to intractable symptoms. MGB’s anatomical configuration through its long, narrow, and vertical pouch, which is based on the lesser curvature, makes esophageal BR highly improbable [7]. Our OAGB with its anti-reflux technique and longer segment of bypassed small bowel (Fig. 1) take this procedure a step further [10]. The case reported by Facchiano et al. [1] is illustrative in several ways. They clearly describe endoscopic and operative findings, and identify a rather short pouch as the potential cause of BR. When reoperations due to “intractable” BR have been carried out, such accounts have not always been given [6]; this information is quite valuable and its reporting should be encouraged.
 
7.
For the very few patients that require a reoperation due to intractable BR, alternatives include Braun entero-enterostomy (EE) and conversion to Roux-en-Y gastric bypass (RYGB) with or without gastric pouch shortening [6, 14, 22]. Precise anatomical details are needed before a decision among these options is taken. Whereas gastric reservoir delineation may be achieved preoperatively (through an upper gastrointestinal swallow and/or endoscopy), information about limb lengths must be obtained intraoperatively. Technically, the easiest alternative is the Braun EE [6, 7, 15]. This was successfully performed by Kular et al. [13] in only one patient (out of 18 with BR) that required a reoperation in their series (0.09 %). Since bile is not completely diverted, a short gastric pouch (such as the one in Facchiano et al. case [1]) would perhaps be a contraindication for this operation. Conversely, an increased incidence of marginal ulcer has been a concern leading some to propose a formal (complete) conversion to RYGB, which is the most cumbersome procedure. In order to restore the digestive tract, it requires anastomotic resection followed by an EE; RYGB is then constructed by pouch shortening and a (regular) 1.5-m-long alimentary limb. This has been done with excellent results at a mean of ∼2 years after OAGB by Chevallier et al. in 7 (0.7 %) patients who also kept their weight loss in their series [14]. A less technically demanding option is conversion to RYGB without resection of the anastomosis and pouch shortening. Division of the afferent loop close to the gastro-enteric anastomosis is followed by an EE to form the alimentary (Roux) limb. This latter measured 50 cm in 3 (0.2 %) patients in the Lee et al. series [22] and 70 cm in 4 (0.4 %) patients in the Noun et al. series [11] and also in the current report of Facchiano et al. [1]. We believe concern in regard to marginal ulcer is unfounded. Its incidence after such reoperations should not be different from that of primary MGB/OAGB whose range is 0.6–4 % [2, 3], and is similar or even lower than that of RYGB [23].
 
Literatur
1.
Zurück zum Zitat Facchiano E, Leuratti L, Veltri M, et al. Laparoscopic conversion of one anastomosis gastric bypass to Roux-en-Y gastric bypass for chronic bile reflux. Ob Surg. 2016. doi:10.1007/s11695-015-2017-8. Facchiano E, Leuratti L, Veltri M, et al. Laparoscopic conversion of one anastomosis gastric bypass to Roux-en-Y gastric bypass for chronic bile reflux. Ob Surg. 2016. doi:10.​1007/​s11695-015-2017-8.
2.
Zurück zum Zitat Mahawar KK, Jennings N, Brown J, et al. “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg. 2013;23:1890–8.CrossRefPubMed Mahawar KK, Jennings N, Brown J, et al. “Mini” gastric bypass: systematic review of a controversial procedure. Obes Surg. 2013;23:1890–8.CrossRefPubMed
3.
Zurück zum Zitat Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini-gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10:984–91.CrossRefPubMed Georgiadou D, Sergentanis TN, Nixon A, et al. Efficacy and safety of laparoscopic mini-gastric bypass. A systematic review. Surg Obes Relat Dis. 2014;10:984–91.CrossRefPubMed
4.
Zurück zum Zitat Deitel M. Mini-gastric (one-anastomosis) bypass becoming a mainstream operation. Bariatric News, issue 18, Dec. 2013 – page 13. Deitel M. Mini-gastric (one-anastomosis) bypass becoming a mainstream operation. Bariatric News, issue 18, Dec. 2013 – page 13.
6.
Zurück zum Zitat Johnson WH, Fernandez AZ, Farrell TM, et al. Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):37–41.CrossRefPubMed Johnson WH, Fernandez AZ, Farrell TM, et al. Surgical revision of loop (“mini”) gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):37–41.CrossRefPubMed
7.
Zurück zum Zitat Rutledge R, Walsh T. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15:1304–8.CrossRefPubMed Rutledge R, Walsh T. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15:1304–8.CrossRefPubMed
8.
Zurück zum Zitat Musella M, Milone M. Still “controversies” about the mini gastric bypass? Ob Surg. 2014;24:643–4.CrossRef Musella M, Milone M. Still “controversies” about the mini gastric bypass? Ob Surg. 2014;24:643–4.CrossRef
9.
Zurück zum Zitat Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–52.PubMed Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–52.PubMed
10.
Zurück zum Zitat Carbajo M, Garcia-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.CrossRefPubMed Carbajo M, Garcia-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.CrossRefPubMed
11.
Zurück zum Zitat Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short and long-term outcome. Obes Surg. 2012;22:697–703.CrossRefPubMed Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short and long-term outcome. Obes Surg. 2012;22:697–703.CrossRefPubMed
12.
Zurück zum Zitat Musella M, Sousa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multi-center review. Surg Endosc. 2014;28:156–63.CrossRefPubMed Musella M, Sousa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multi-center review. Surg Endosc. 2014;28:156–63.CrossRefPubMed
13.
Zurück zum Zitat Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses—first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.CrossRefPubMed Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses—first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.CrossRefPubMed
14.
Zurück zum Zitat Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8.CrossRefPubMed Chevallier JM, Arman GA, Guenzi M, et al. One thousand single anastomosis (omega loop) gastric bypasses to treat morbid obesity in a 7-year period: outcomes show few complications and good efficacy. Obes Surg. 2015;25:951–8.CrossRefPubMed
15.
Zurück zum Zitat Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. DOI 10.1007/s11695-015-1869-2 Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, Roux-En-Y gastric bypass, and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. DOI 10.​1007/​s11695-015-1869-2
16.
Zurück zum Zitat Tolone S, Cristiano S, Savarino E, et al. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Rel Dis. 2016;12:62–9.CrossRef Tolone S, Cristiano S, Savarino E, et al. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Rel Dis. 2016;12:62–9.CrossRef
17.
Zurück zum Zitat McQuaid KR, Laine L, Fennerty MB, et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34(2):146–65.CrossRefPubMed McQuaid KR, Laine L, Fennerty MB, et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34(2):146–65.CrossRefPubMed
18.
Zurück zum Zitat Seoane A, Bessa X, Alameda F, et al. Role of Helicobacter pylori in stomach cancer after partial gastrectomy for benign ulcer disease. Rev Esp Enferm Dig. 2005;97(11):778–85.CrossRefPubMed Seoane A, Bessa X, Alameda F, et al. Role of Helicobacter pylori in stomach cancer after partial gastrectomy for benign ulcer disease. Rev Esp Enferm Dig. 2005;97(11):778–85.CrossRefPubMed
19.
Zurück zum Zitat Babor R, Booth M. Adenocarcinoma in the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16:935–8.CrossRefPubMed Babor R, Booth M. Adenocarcinoma in the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16:935–8.CrossRefPubMed
20.
Zurück zum Zitat Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.CrossRefPubMed Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.CrossRefPubMed
21.
Zurück zum Zitat Wu CC, Lee WJ, Ser KH, et al. Gastric cancer after mini-gastric bypass surgery: a case report. Asian J Endosc Surg. 2013;6:303–6.CrossRefPubMed Wu CC, Lee WJ, Ser KH, et al. Gastric cancer after mini-gastric bypass surgery: a case report. Asian J Endosc Surg. 2013;6:303–6.CrossRefPubMed
22.
Zurück zum Zitat Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis. 2011;7(4):486–92.CrossRefPubMed Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis. 2011;7(4):486–92.CrossRefPubMed
23.
Zurück zum Zitat Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.CrossRefPubMed Coblijn UK, Goucham AB, Lagarde SM, et al. Development of ulcer disease after Roux-en-Y gastric bypass, incidence, risk factors and patient presentation: a systematic review. Obes Surg. 2014;24(2):299–309.CrossRefPubMed
Metadaten
Titel
Conversion of One-Anastomosis Gastric Bypass (OAGB) Is Rarely Needed if Standard Operative Techniques Are Performed
verfasst von
Enrique Luque-de-León
Miguel A. Carbajo
Publikationsdatum
11.04.2016
Verlag
Springer US
Erschienen in
Obesity Surgery / Ausgabe 7/2016
Print ISSN: 0960-8923
Elektronische ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-016-2172-6

Weitere Artikel der Ausgabe 7/2016

Obesity Surgery 7/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.